Title
Category
Credits
Event date
Cost
Treatment of Clostridioides difficile Infection
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This program will describe the risk factors associated with C. difficile infection (CID) and will focus on the current recommended treatment options, both pharmacotherapy and non-pharmacotherapy.  Additionally, the program will discuss new options that have recently come to the market for the treatment and prevention of CDI.
The Treatment of Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP)
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This is part of the CE programming on Improving Antimicrobial Stewardship Across Alabama (IASAA). Specifically this CE will evaluate the treatment of HAP and VAP.This program is sponsored through a grant from the Alabama Department of Public Health, Bureau of Communicable Disease Infectious Diseases and Outbreaks through a Cooperative Agreement with the Centers for Disease Control and Prevention, grant number 6 NU50CK000545-03-02, Strengthening HAI/AR (SHARP) CFDA 93.323.
Sepsis Stewardship: Treatment of Sepsis and Septic Shock
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will discuss the treatment of sepsis and septic shock. It will discuss how to prioritize treatment choices, practical logistic needs and applications, and how to de-escalate therapy as the patient recovers.This program is sponsored through a grant from the Alabama Department of Public Health, Bureau of Communicable Disease Infectious Diseases and Outbreaks through a Cooperative Agreement with the Centers for Disease Control and Prevention, grant number 6 NU50CK000545-03-02, Strengthening HAI/AR (SHARP) CFDA 93.323.
Recorded Treatment of Skin and Soft Tissue Infections (SSTIs), Diabetes-related Foot Infections (DFIs) and Osteomyelitis
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.80 ABN
  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit™
$0.00
Skin and soft tissues infections, diabetes-related foot infections, and osteomyelitis are frequently occurring infections among patients in both the inpatient and outpatient settings. Appropriate classification of these infections and recognition of the corresponding common causative pathogen are essential to determine optimal empiric antimicrobial therapy. This presentation will review types of SSTI and osteomyelitis along with common pathogens and discuss aspects of antimicrobial therapy for treatment of SSTI and osteomyelitis, including dosing, route, monitoring parameters and duration.
Recorded Treatment of Urinary Tract Infections
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.80 ABN
  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit™
$0.00
Urinary tract infections (UTIs) are one of the most common indications for receipt of antimicrobial therapy in both the community, hospital, and long-term care settings.  However, inappropriate use of broad-spectrum antibiotics for the treatment of UTIs has significantly contributed to the development of antimicrobial resistance to UTI pathogens.
Recorded Introduction to Antimicrobial Stewardship
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will explore the concept of antimicrobial stewardship, emphasizing its clinical relevance and importance. Participants will be able to identify the Center for Disease Control (CDC)’s Core Elements of antimicrobial stewardship, discuss strategies to improve inappropriate antibiotic use, and review resources available to assist healthcare professionals with clinical decision-making related to antibiotics. The session will be interactive, featuring case vignettes to enhance learning and application.
Recorded National Regulatory Requirements for Antibiotic Stewardship in Acute Care Hospitals
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
Antibiotic Stewardship is required for acute care hospitals participating in the Center for Medicaid/Medicare reimbursement programs and for those seeking/maintaining Joint Commission accreditation status. This program will provide a comprehensive review of these guidelines and provide updates regarding recent changes.
Recorded Bugs & Drugs: An Antimicrobial Agents Review
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 2.40 ABN
  • 2.00 ACPE Pharmacy
  • 2.00 AMA PRA Category 1 Credit™
$0.00
The cornerstone of antimicrobial stewardship is the correct use of antimicrobial agents.  In order to use antimicrobial agents correctly, clinicians must be familiar with the drugs themselves, including their spectrum activity, mechanisms of action, adverse effect profile, and major drug interactions. Additionally, multiple new agents have been brought to the market in recent years, and clinicians must be aware of where these new agents fit into clinical practice.
Recorded Treatment of Community-Acquired Pneumonia
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will review the diagnosis and recommended treatment of community acquired pneumonia for all practice settings as well as treatment considerations when selecting appropriate therapy. Furthermore, strategies to promote antimicrobial stewardship in the treatment of community acquired pneumonia will be discussed.
Antimicrobial Stewardship in the Intensive Care Unit
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation focuses on the critical role of antimicrobial stewardship (AMS) in the Intensive Care Unit (ICU), where patients are highly susceptible to infections and often exposed to broad spectrum antibiotics. Pharmacists play a key role in implementing AMS strategies to optimize antimicrobial use, reduce resistance, and improve patient outcomes.